Galmed Pharmaceuticals Ltd. GLMD 深 沪
等待开盘 06-25 09:30:00 美东时间
0.5875
+0.016
+2.71%
华盛通- 最 高0.5923
- 今 开0.555
- 成交量 6.54万股
- 最 低 0.5471
- 昨 收 0.572
- 总市值 387.73万
- 52周最高 2.34
- 市盈率 静 --
- 换手率 0.99%
- 52周最低 0.4111
- 委 比 42.86%
- 总股本 659.97万
- 历史最高 4870.80
- 量 比 0.31
- 振 幅 7.90%
- 历史最低 0.4111
- 每 手 1
- 风险率 0.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Galmed Agrees With Acquisition Target Colospan To Increase The Cash Portion Of Purchase Price By $800K In Lieu Of Issuing $2M In Shares
Colospan Ltd. ("Colospan") provides Galmed Pharmaceuticals Ltd. ("Galmed") (NASDAQ:GLMD) with a commercially ready product in the EU/Israel (CE marked under MDR) with a dedicated OPS code to accelerate reimbursement in Germany Strategic and Financial Highlights Restructured Anti-Dilutive Financial T...
06-22 19:30
Galmed Pharmaceuticals Ltd.宣布调整Colospan Ltd.收购条款 优先推进CG-100欧洲商业化 保障股东价值并完成收购
纳斯达克上市药企加尔梅德（GLMD）完成对商业化阶段医疗器械企业科隆 span的收购，后者成为其全资子公司。 本次收购调整原反稀释财务条款：取消原定交易完成时发...
06-22 19:06
Galmed Reports Preclinical Results for Heart Disease Drug Combination, Study Identifies New Pathway Linked to Cardiac Fibrosis
Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, today announced
06-02 19:38
Galmed Pharmaceuticals Announces Milestone Results From Phase 1 PK Study In Healthy Subjects; 400mg AM Increases Bioavailability By ~500% In Comparison To Aramchol Free Acid 300mg
Results from Study AM-001 mark a pivotal advance through the transition to a once daily lower 400mg dose of AM enabling:Production of GMP clinical batch for Galmed's upcoming clinical trialsSolidification and
05-14 19:38
Tissue Dynamics, Galmed Pharmaceuticals Partner To Develop Novel Human Chronic Fibrosis Model
Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver disease and GI oncological therapeutics, today announced a
05-06 19:37
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 19.1% to $16.23 during ...
04-25 05:05
Galmed Stock Soars On Brain-Penetrating Aramchol Formulation
Galmed Pharmaceuticals Ltd. shares are trading higher after it announced the development of a brain penetrating new formulation of Aramchol.
04-09 23:04
Galmed Pharmaceuticals shares are trading higher after the company announced the development of a brain penetrating new formulation of Aramchol.
Galmed Pharmaceuticals shares are trading higher after the company announced th...
04-09 20:39
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galmed Pharmaceuticals (NASDAQ:GLMD) stock increased by 83.2% to $1.14...
04-09 20:05
Galmed Pharmaceuticals Receives Nasdaq Noncompliance Notice, Gets Time Through July 28 To Regain Compliance
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, today announced that the Company
01-31 05:15
